Dr Moran has over 20 years experience in health policy and practice, including 10 years specialising in neglected disease policy. She has conducted projects for a wide range of public and multilateral health organisations with a focus on policy solutions for emerging issues related to neglected disease R&D. In 2004, Mary founded the research group that became Policy Cures at the London School of Economics & Political Science, later transferring it to the George Institute for International Health in Sydney.
Prior to forming the group, she worked for over a decade in Emergency Medicine; was a diplomat and policy analyst with the Australian Department of Foreign Affairs & Trade; Director of Medecins Sans Frontieres Access to Essential Medicines Campaign in Australia; and a Europe-based policy advocate with MSF on issues relating to access to medicines for neglected patients. Mary is an Honorary Senior Lecturer at the London School of Hygiene and Tropical Medicine, and an Expert Adviser to the World Health Organisation, European Commission, European and Developing Countries Clinical Trials Partnership, Global Alliance for Vaccines and Immunisation (GAVI), OECD and the Wellcome Trust.
Javier Guzman has worked in public health policy and practice for 12 years, specialising in neglected disease policy since 2004. Javier trained as a physician, working for several years in planning and implementation of primary health care projects in Colombia and subsequently as a Post Graduate Clinical Fellow in Paediatrics at the Royal London Hospital.
Javier has been with the Policy Cures team since 2004, and as Director of Research since 2009. He is an Honorary Lecturer at the London School of Hygiene and Tropical Medicine and the University of Sydney, and an expert adviser to the European and Developing Countries Clinical Trials Partnership and the Global Alliance for Vaccines and Immunisation (GAVI). He has an MSc in Health Policy, Planning and Financing from the LSE and the London School of Hygiene and Tropical Medicine and is currently doing an MBA-Executive at the Australian Graduate School of Management, Sydney.
Nick Chapman has over 5 years’ experience in health policy and practice as a doctor, research associate and analyst. In his role with Policy Cures, Nick has worked on projects for governments, major philanthropic organisations and public-private partnerships. His experience includes work on strategy development, funding gap analysis and innovative financing mechanisms. He has been a guest lecturer at the University of Sydney, and has played an active role in Policy Cures’ efforts to raise the profile of global health R&D in Australia.
Nick began his career as a doctor in Tasmania before obtaining a Master’s degree in human rights, focusing on international development and international law. Prior to joining Policy Cures, Nick worked with Oxfam Australia and the Australian Human Rights Commission, predominantly on policy solutions to Indigenous health inequality.
Nick has a Bachelor of Medicine/Bachelor of Surgery (1st class Honours) and a Bachelor of Medical Science from the University of Tasmania, and a Master of Human Rights (with Merit) from the University of Sydney.
Plum has seven years’ post Masters experience in healthcare policy, public affairs and advocacy campaigning. She has previously worked on a number of award-winning global advocacy campaigns, including World Hepatitis Day and Earth Hour, and also with the UK based American Pharmaceutical Group, on their access to medicines in the developing world programme.
Prior to returning to Australia in early 2010 Plum lived and worked in London with experience that includes working in the parliamentary office of the Parliamentary Under-Secretary of State for Health and for the general practitioners committee of the British Medical Association.
Plum has a strong health policy background with a MSc in public health nutrition from the London School of Hygiene and Tropical Medicine, and has written a number of policy papers, particularly relating to tackling childhood obesity and flu pandemic preparedness. Plum joined the Policy Cures team in February 2013.
Lindsey has 4 years experience in health policy, including as a healthcare policy consultant for The Lewin Group in Washington, DC, focussing on health technology assessments for the Agency for Healthcare Research and Quality (AHRQ), clinical data analysis for the National Institutes of Health (NIH), and evidence-based reviews of pharmacogenomics for the US Department of Health and Human Services (DHHS).
Lindsey received a Bachelors of Applied Science in Biotechnology and a BA in Economics from the University of Pennsylvania, and an MSc from the London School of Economics, where she focussed on the WTO TRIPS Agreement and its impact on the global pharmaceutical industry. Lindsey joined the team as a Research Associate in February 2008.
Lisette has 5 years experience as a commercial analyst of the pharmaceutical industry. In her last role working for business information company Datamonitor, she focused on collecting and analyzing market data and formulating strategic insights and recommendations for the pharmaceutical sector. Lisette also worked as a volunteer in several projects in Kenya and Chile focusing on sexual health education.
She received a Bachelor of Health in Occupational Therapy from the Hogeschool van Amsterdam, The Netherlands, and a Master of Public Health from Maastricht University, The Netherlands. Lisette joined the Policy Cures team in October 2010.
Rachel has previously worked as a Research Assistant where she focused on market research and product development. In 2011, she was an intern with the Australian Trade Commission in Paris, where she conducted research and assisted in assessing the investment readiness of foreign companies in the Australian Clean Technology sector; updated industry profiles on the Health and Medical Services, Biotechnology, and Financial Services’ markets; and was involved in the promotion of Australian education abroad.
Rachel has a Bachelor of International Relations from Bond University on the Gold Coast, focusing on international and regional development issues. She joined the Policy Cures team in January 2013.
Emily has worked as a Research and Project Management Assistant at the Health & Sustainability Unit of the Boden Institute, the Sydney Medical School, where she published journal articles on the link between social injustice and health. She has also been an intern in India with the NGO EduCARE India. Throughout her internship she worked on a number of developmental projects concerning health, rural waste management and sanitation.
Emily has a Bachelor of International and Global Studies (Honours) from the University of Sydney, where she focused on the socio-economic causes of emerging health issues in the Pacific Islands region. She joined the Policy Cures team in January 2013.
Stephen brings qualifications and experience in accountancy and IT to the management of the financial and business systems aspects of the organisation. Reporting to the Executive Director, Stephen is responsible for day to day management of Policy Cures’ financial stability, foreign exchange risk, IT infrastructure, contracts, and web presence.
The role of Business Manager is also responsible for conceptualising and implementing effective information systems, tools, and strategies for enhanced management decision making and control at both the project and enterprise level and for long-term organisational sustainability. Stephen joined the Policy Cures team in April 2011.
Susan has many years experience as both a personal and administrative assistant with a range of major Australian firms in the legal, accounting, executive search, insurance and telecommunications sectors, including Freehills, Blake Dawson Waldron, Egon Zehnder International and Quantum Group. She was also PA to the CEO of the NSW State Rail Authority. Susan joined the team in August 2009.